Symptomtext
a 71-year-old female was given Adacel as a tetanus booster that was out of the age range, with no reported adverse event; Initial information was received on 11-Oct-2021 regarding an unsolicited valid non-serious case received from a nurse via consumer via physician (under Medical Information (MI) Inquiry Number: 00807107). This case involves a 71- years old female patient who was administered with DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] as a tetanus booster with no reported adverse event (product administered to patient of inappropriate age). The patient's medical history, past medical treatments, vaccinations and family history were not provided. On 02-Apr-2021, the patient received a 0.5 ml booster dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot number: U6807BB and expiry date: 10-Sep-2022 via intramuscular route in the left deltoid for prophylactic vaccination. It was a case of actual medication error due to inappropriate age at vaccine administration (latency: same day). At the time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.